Orthostatic Hypertension: Critical Appraisal of an Overlooked Condition.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 1 4 2020
medline: 7 4 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

Orthostatic hypertension, which appears to be mediated through excess neurohumoral activation while standing, is a common blood pressure trait among patients with and without arterial hypertension. However, lack of consensus regarding the definition of orthostatic hypertension makes it difficult to assess the true prevalence of this condition. Orthostatic hypertension appears to predict the risk for progression to arterial hypertension in younger and risk of cardiovascular morbidity and mortality in older persons. Yet, the risk may differ between populations. Whether orthostatic hypertension indicates a generally increased risk of death, constitutes an intermediate variable in the causal pathway of cardiovascular risk factors, a simple measure of disease severity, or an independently acting mechanism is not known. Since both orthostatic hypotension and orthostatic hypertension herald increased risk of cardiovascular disease, it appears reasonable to screen the patients for abnormal orthostatic blood pressure responses using simple orthostatic testing. However, how presence of orthostatic hypertension may affect clinical management decisions such as the choice of antihypertensive drugs is currently difficult to ascertain. Clearly, this issue deserves more attention.

Identifiants

pubmed: 32223382
doi: 10.1161/HYPERTENSIONAHA.120.14340
doi:

Substances chimiques

Antihypertensive Agents 0
Norepinephrine X4W3ENH1CV

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1151-1158

Auteurs

Jens Jordan (J)

From the Institute of Aerospace Medicine, German Aerospace Center (DLR) and Chair of Aerospace Medicine (J.J., F.H.), University of Cologne, Germany.
University Hypertension Center (J.J., F.H.), University of Cologne, Germany.

Fabrizio Ricci (F)

Department of Clinical Sciences, Lund University, Malmö, Sweden (F.R., V.H., A.F.).
Department of Neuroscience, Imaging and Clinical Sciences, "G.d'Annunzio" University, Chieti-Pescara, Italy (F.R.).

Fabian Hoffmann (F)

From the Institute of Aerospace Medicine, German Aerospace Center (DLR) and Chair of Aerospace Medicine (J.J., F.H.), University of Cologne, Germany.
University Hypertension Center (J.J., F.H.), University of Cologne, Germany.

Viktor Hamrefors (V)

Department of Clinical Sciences, Lund University, Malmö, Sweden (F.R., V.H., A.F.).
Department of Internal Medicine (V.H.), Skåne University Hospital, Malmö, Sweden.

Artur Fedorowski (A)

Department of Clinical Sciences, Lund University, Malmö, Sweden (F.R., V.H., A.F.).
Department of Cardiology (A.F.), Skåne University Hospital, Malmö, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH